Anastomosis Devices Market

Anastomosis Devices: An Overview

Anastomosis is the surgical technique that creates a connection between two hollow or tubular structures in the body. Anastomosis devices are tools or instruments that are used in surgical procedures to perform anastomosis. The devices come in different types, each designed for specific anatomical structures and surgical procedures. The use of anastomosis devices has revolutionized surgical procedures and improved patient outcomes. This essay will provide an overview of anastomosis devices, their types, and their applications.

Types of Anastomosis Devices

Staplers

Staplers are the most commonly used anastomosis devices. They are designed to perform end-to-end, end-to-side, or side-to-side anastomosis in tubular or hollow structures. Staplers are available in different sizes and types, including linear and circular staplers. Linear staplers are used for end-to-end and end-to-side anastomosis, while circular staplers are used for side-to-side anastomosis. Staplers work by cutting and stapling the tissue, which creates a secure connection between the two structures.

Sutures

Sutures are used to perform anastomosis in structures that cannot be stapled, such as small vessels and nerves. They are available in different types, including absorbable and non-absorbable sutures. Absorbable sutures are used for structures that do not require permanent closure, while non-absorbable sutures are used for permanent closure. Sutures work by sewing the two structures together using a needle and thread.

Clips

Clips are used to perform anastomosis in small blood vessels and bile ducts. They work by clamping the two structures together, which creates a secure connection. Clips are available in different sizes and types, including titanium and plastic clips.

Applications of Anastomosis Devices

Gastrointestinal Surgery

Anastomosis devices are commonly used in gastrointestinal surgery to create connections between the different parts of the digestive system. Staplers are used to perform anastomosis in the esophagus, stomach, and intestines, while sutures and clips are used for smaller structures such as the bile ducts.

Cardiovascular Surgery

Anastomosis devices are used in cardiovascular surgery to create connections between blood vessels. Staplers are used to perform anastomosis in larger vessels, while sutures and clips are used for smaller vessels and nerves.

Plastic Surgery

Anastomosis devices are used in plastic surgery to connect blood vessels and nerves in tissue reconstruction procedures. Sutures and clips are commonly used for anastomosis in plastic surgery procedures.

Dynamics of Anastomosis Devices Market

Drivers in Anastomosis Devices Market

The Anastomosis Devices Market is driven by various factors. One of the primary drivers is the increasing number of surgical procedures being performed worldwide. According to statistics, an astounding 310 million major surgeries are carried out every year on a global scale, with approximately 40 to 50 million procedures taking place in the US alone and 20 million in Europe. This rise in surgeries is largely due to the growing elderly population and the increasing prevalence of chronic diseases. Lifestyle disorders such as cardiac diseases, diabetes, hypertension, obesity, and cancer are becoming more common, not just among the elderly but also among younger generations. As a result, the demand for anastomosis devices is set to increase since they aid in faster recovery, reduced blood loss, and minimal scarring.

Opportunities in Anastomosis Devices Market

However, the pandemic has presented challenges for general surgery practices, including changes in surgical techniques, patient and staff safety, and workflow. Elective and semi-elective procedures, including gastrointestinal malignancies, have been postponed. Despite this, the market is expected to experience a surge in demand once surgeries resume at full force.

The growing healthcare markets in emerging economies also provide a significant opportunity for major market players. Countries such as India, South Korea, Malaysia, Vietnam, Africa, and the Middle East, including Israel, Saudi Arabia, and the UAE, have low regulatory barriers, improved healthcare infrastructure, a growing patient population, and increased healthcare expenditure. Additionally, the regulatory policies in the Asia-Pacific region are more adaptable and business-friendly than those in developed countries. These factors, coupled with increasing competition in mature markets, have compelled key players in the global market to focus on emerging economies.

Constraints in Anastomosis Devices Market

The cost of anastomosis devices and the need for extensive clinical data for launching new products are major challenges in this market. Developing surgical sealants and adhesives is a costly process that requires significant investments in research and development. Product development involves expensive production processes such as freeze-drying, refrigerated storage, and complicated device preparation. In addition, surgical staplers are more expensive than traditional sutures, which increases the overall cost of surgical procedures. As healthcare providers are trying to reduce costs, the high prices of anastomosis devices may limit their demand, particularly in developing countries.

Challenges in Anastomosis Devices Market

The proper utilization of anastomosis devices requires skilled personnel. The successful outcome of surgical procedures depends heavily on the experience and knowledge of the personnel using the devices. For example, tissue compression and the integrity of staple lines are crucial factors for creating a stable anastomosis. Improper use of surgical staplers due to a lack of training or knowledge can lead to potentially life-threatening complications. Surgeons must also consider tissue thickness and type when selecting the correct size of staples for a particular surgical procedure. The demand for better patient outcomes will drive the adoption of innovative anastomosis devices, such as the EEA Circular Stapler with Tri-Staple Technology, which was introduced in 2020 by India Medtronic Private Limited.

The anastomosis device market is growing due to the introduction of technologically-advanced products and favorable reimbursement scenarios for cardiac procedures in developed countries. Medicare Part B covers coronary artery bypass graft surgery, coronary angioplasty, valve repair and replacement, and comprehensive cardiac rehabilitation programs. The market is dominated by a few key players, including Johnson & Johnson, Medtronic Plc, B. Braun Melsungen, Intuitive Surgical Inc., Boston Scientific Corporation, and Artivion, Inc. These companies are leaders in the market due to their extensive product portfolios and global reach.

Ecosystem of Anastomosis Devices Market

The anastomosis devices market is segmented into three categories: surgical staplers, surgical sutures, and surgical sealants and adhesives. During the forecast period, the surgical staplers segment is expected to hold the largest share of the global market. This can be attributed to the numerous advantages of surgical staplers such as ease of use, reduced risk of complications, minimal blood loss and leakage, and shorter operating time. In comparison, surgical sutures, sealants, and adhesives are less popular among healthcare professionals.

Among the different applications of anastomosis devices, cardiovascular and thoracic surgery segment is projected to hold the largest share of the market during the forecast period. This can be attributed to the increasing prevalence of cardiovascular and thoracic diseases and the extensive use of anastomosis devices in these surgeries. The other applications of anastomosis devices include gastrointestinal surgery, orthopaedic surgery, gynaecological surgery, and others.

Hospitals are expected to be the largest end-users of anastomosis devices during the forecast period. The increasing number of complex surgeries performed in hospitals, growing prevalence of various diseases, and favourable compensation policies for hospital treatments are contributing to the growth of this segment. The other end-users of anastomosis devices include ambulatory surgery centers and other healthcare facilities.

In summary, the anastomosis devices market is expected to experience significant growth during the forecast period. The surgical staplers segment, cardiovascular and thoracic surgery application, and hospitals end-user segment are projected to hold the largest share of the market. The growth can be attributed to the numerous advantages associated with surgical staplers, rising incidence of cardiovascular and thoracic diseases, and the increasing number of intricate surgeries performed in hospitals.

The anastomosis devices market is divided into five major regions, namely North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America holds the largest share of the anastomosis device market. This growth can be attributed to the large volume of surgical procedures performed and favourable reimbursement scenario. During the forecast period, North America accounted for the largest revenue share of over 43%. The region's market is expected to grow due to the increasing prevalence of cardiovascular diseases and the growing number of R&D collaborations among major players.

Factors contributing to the growth of the North American market include increasing access to medical assistance, rising awareness regarding CVD and CHD, growing disposable income, and a well-established R&D infrastructure. In contrast, the Asia Pacific (APAC) region is expected to register the highest CAGR over the forecast period, with Japan, China, and India being the key contributors to the APAC market. The region is estimated to experience the fastest growth during the forecast period due to improving economic conditions, increasing healthcare awareness, and the growing aging population in the region. Elderly people are more prone to cardiovascular and gastrointestinal diseases, making them a huge target population for the industry.

The market is anticipated to be driven by the rising interest of companies to expand their presence in the region and the growing demand for anastomosis devices. Additionally, increasing R&D activities and soaring healthcare expenditure are working in favor of the regional market.

During the forecast period, the disposable segment is expected to dominate the anastomosis device market, accounting for over 85.4% of the revenue share. This is due to the wider availability of disposable anastomotic products and their greater market penetration. Most major players in the market produce disposable products because they reduce the risk of Surgical Site Infections (SSI) and other Healthcare-associated Infections (HAI), as well as cross-contamination. Furthermore, disposable devices do not require reprocessing between uses, which reduces costs and speeds up the entire process. As a result of these advantages, this segment is expected to experience strong growth in the future.

The reusable anastomotic device segment is a growing market, with a projected lucrative CAGR over the forecast period. The development of technologically-advanced products and the increasing need to reduce biomedical waste are expected to drive the growth of this segment in the coming years. As healthcare providers become more aware of the impact of medical waste on the environment, they are likely to adopt reusable anastomotic devices, which can be sterilized and reused multiple times, resulting in lower waste production. Technological advancements in the production of reusable devices will also contribute to the growth of this segment.

During the forecast period, cardiovascular surgery is expected to hold the most significant revenue share of over 54%. The increasing prevalence of Cardiovascular Diseases (CVD) is contributing to the growth of heart surgeries such as CABG. According to the World Health Organization (WHO), an estimated 19.9 million people died from CVD during the forecast period, representing 31% of all global deaths.

The gastrointestinal surgery segment, including colorectal surgeries and large bowel resections, is anticipated to witness tremendous growth over the forecast period. This can be attributed to the rising prevalence of colorectal cancer and other gastrointestinal diseases that require bowel resection. The American Cancer Society (ACS) reports that although there has been a steady decline in the incidence of colon and rectal cancer among adults aged 50 and older over the past several decades, the incidence of these cancers has been rising among younger adults. However, death rates from these cancers have been declining, which is largely attributed to increased screening and improved treatment options.

The ACS recommends that adults at average risk for colon and rectal cancer begin regular screening at age 45, while those at higher risk may need to start screening earlier. Early detection through screening is critical for successful treatment and can even prevent cancer from developing in the first place. The prevalence of colorectal cancer is increasing in the Asia Pacific region, providing a significant growth opportunity for the anastomosis devices market. According to reports, East Asian countries such as Japan, China, South Korea, and Singapore have exhibited a two to four-fold increase in incidence over the last decade. Moreover, a large number of products for use in gastrointestinal anastomosis are expected to be introduced in the market over the forecast period, providing a lucrative growth platform to the market in the near future.

Dominating Companies in Anastomosis Devices Market

• JOHNSON & JOHNSON
• MEDTRONIC PLC
• B. BRAUN MELSUNGEN AG
• BOSTON SCIENTIFIC CORPORATION
• ARTIVION, INC.
• INTUITIVE SURGICAL, INC.
• SMITH & NEPHEW PLC
• BECTON, DICKINSON AND COMPANY
• CONMED CORPORATION
• BAXTER INTERNATIONAL INC.
• ADVANCED MEDICAL SOLUTIONS GROUP PLC (AMS GROUP)
• TELEFLEX
• MERIL LIFE SCIENCES PVT. LTD.
• SURGICAL SPECIALTIES CORPORATION
• PÉTERS SURGICAL
• DEMETECH CORPORATION
• PURPLE SURGICAL
• FRANKENMAN INTERNATIONAL LTD.
• BIOSINTEX
• LOTUS SURGICALS
• ENDOEVOLUTION, LLC
• MELLON MEDICAL B.V.
• INTERNACIONAL FARMACÉUTICA S.A. DE C.V.
• WELFARE MEDICAL LTD.
• UNISUR LIFECARE PVT. LTD
• LivaNova PLC
• MAQUET Holding B.V. & Co. KG.
• Dextera Surgical Inc.
• Vitalitec Internaional Inc.
• Synovis Micro Companies Alliance, Inc.
• Ethicon US, LLC
• Peters Surgical

Recent Developments in Anastomosis Devices Market

• Intuitive Surgical Acquires Orpheus Medical: In May 2021, Intuitive Surgical, a leading provider of robotic-assisted surgical systems, acquired Orpheus Medical, a company that specializes in software solutions for managing and sharing surgical video and images. This acquisition is expected to enhance Intuitive's digital ecosystem and improve the efficiency of surgical workflows, particularly in the field of anastomosis.
• Becton, Dickinson and Company Acquires TVA Medical: In 2019, Becton, Dickinson and Company (BD) acquired TVA Medical, a medical device company that develops minimally invasive solutions for patients with chronic kidney disease. TVA Medical's innovative technology, the everlinQ endoAVF System, is designed to create a minimally invasive arteriovenous fistula (AVF) for hemodialysis patients. This acquisition has expanded BD's portfolio of endovascular devices and strengthens its presence in the field of vascular access.
• Johnson & Johnson Acquires Auris Health: In February 2019, Johnson & Johnson announced its acquisition of Auris Health, a company that develops robotic technologies for minimally invasive surgical procedures. Auris Health's flagship product, the Monarch Platform, is designed to assist physicians in diagnosing and treating lung cancer. This acquisition has expanded Johnson & Johnson's capabilities in the field of robotic-assisted surgery and positions the company to play a leading role in the development of next-generation anastomosis devices.
• Baxter International Acquires Seprafilm: In January 2021, Baxter International, a global medical products company, acquired Seprafilm, a leader in the development of surgical adhesion prevention solutions. Seprafilm's products are used to reduce the incidence of post-surgical adhesions, which can be a major complication in surgeries involving anastomosis. This acquisition has strengthened Baxter's surgical portfolio and has positioned the company to provide comprehensive solutions for surgical procedures involving anastomosis.
• Medtronic Acquires Klue: In March 2021, Medtronic, a global medical technology company, acquired Klue, a digital health company that specializes in using wearable technology to monitor and analyze hand gestures. Klue's technology is designed to help people manage chronic conditions, including Parkinson's disease and essential tremor. This acquisition has expanded Medtronic's digital health capabilities and may have potential applications in the field of anastomosis, particularly in the development of new devices for minimally invasive surgery.
• Boston Scientific Acquires Veniti: In August 2018, Boston Scientific acquired Veniti, a medical device company that develops venous stent systems for treating venous obstructive disease. Veniti's Vici stent system is designed to treat patients with chronic venous obstructive disease (CVOD), which can occur as a result of anastomotic stenosis or other venous abnormalities. This acquisition has expanded Boston Scientific's portfolio of venous interventions and positioned the company as a leader in the treatment of CVOD.
• Stryker Acquires Invuity: In September 2018, Stryker, a medical technology company, acquired Invuity, a company that develops advanced surgical lighting and visualization solutions. Invuity's products are designed to improve visualization and illumination during surgical procedures, including anastomosis. This acquisition has expanded Stryker's portfolio of surgical devices and has positioned the company to provide comprehensive solutions for surgical procedures involving anastomosis.
• Teleflex Acquires NeoTract: In September 2017, Teleflex, a global provider of medical devices, acquired NeoTract, a company that develops minimally invasive urology devices. NeoTract's UroLift System is designed to treat patients with lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH). The UroLift System uses a minimally invasive approach that can reduce the risk of complications associated with traditional anastomosis procedures. This acquisition has expanded Teleflex's portfolio of minimally invasive urology devices and has positioned the company as a leader in the treatment of BPH.
• AngioDynamics Acquires RadiaDyne: In September 2020, AngioDynamics, a medical device company that specializes in vascular access solutions, acquired RadiaDyne, a company that develops radiation protection products for use in oncology procedures. RadiaDyne's OARtrac System is designed to help reduce radiation exposure during anastomosis procedures for cancer patients. This acquisition has expanded AngioDynamics' portfolio of oncology devices and has positioned the company to provide comprehensive solutions for cancer treatment.
• Abbott Acquires Cephea Valve Technologies: In February 2020, Abbott, a global healthcare company, acquired Cephea Valve Technologies, a company that develops minimally invasive heart valve replacement solutions. Cephea's technology uses a minimally invasive approach that can reduce the risk of complications associated with traditional anastomosis procedures. This acquisition has expanded Abbott's portfolio of structural heart devices and has positioned the company as a leader in the development of next-generation heart valve replacement solutions.

In conclusion, anastomosis devices are essential tools in surgical procedures. They have revolutionized surgical procedures and improved patient outcomes. The devices come in different types, including staplers, sutures, and clips, each designed for specific anatomical structures and surgical procedures. Anastomosis devices are commonly used in gastrointestinal, cardiovascular, and plastic surgery.